242 related articles for article (PubMed ID: 30476079)
1. Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.
Pennells L; Kaptoge S; Wood A; Sweeting M; Zhao X; White I; Burgess S; Willeit P; Bolton T; Moons KGM; van der Schouw YT; Selmer R; Khaw KT; Gudnason V; Assmann G; Amouyel P; Salomaa V; Kivimaki M; Nordestgaard BG; Blaha MJ; Kuller LH; Brenner H; Gillum RF; Meisinger C; Ford I; Knuiman MW; Rosengren A; Lawlor DA; Völzke H; Cooper C; Marín Ibañez A; Casiglia E; Kauhanen J; Cooper JA; Rodriguez B; Sundström J; Barrett-Connor E; Dankner R; Nietert PJ; Davidson KW; Wallace RB; Blazer DG; Björkelund C; Donfrancesco C; Krumholz HM; Nissinen A; Davis BR; Coady S; Whincup PH; Jørgensen T; Ducimetiere P; Trevisan M; Engström G; Crespo CJ; Meade TW; Visser M; Kromhout D; Kiechl S; Daimon M; Price JF; Gómez de la Cámara A; Wouter Jukema J; Lamarche B; Onat A; Simons LA; Kavousi M; Ben-Shlomo Y; Gallacher J; Dekker JM; Arima H; Shara N; Tipping RW; Roussel R; Brunner EJ; Koenig W; Sakurai M; Pavlovic J; Gansevoort RT; Nagel D; Goldbourt U; Barr ELM; Palmieri L; Njølstad I; Sato S; Monique Verschuren WM; Varghese CV; Graham I; Onuma O; Greenland P; Woodward M; Ezzati M; Psaty BM; Sattar N; Jackson R; Ridker PM; Cook NR; D'Agostino RB; Thompson SG; Danesh J; Di Angelantonio E;
Eur Heart J; 2019 Feb; 40(7):621-631. PubMed ID: 30476079
[TBL] [Abstract][Full Text] [Related]
2. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
3. Recalibration of the SCORE risk chart for the Russian population.
Jdanov DA; Deev AD; Jasilionis D; Shalnova SA; Shkolnikova MA; Shkolnikov VM
Eur J Epidemiol; 2014 Sep; 29(9):621-8. PubMed ID: 25179794
[TBL] [Abstract][Full Text] [Related]
4. Recalibration of the Framingham risk score for predicting 10-year risk of cardiovascular events: A non-concurrent rural cohort study from Tamil Nadu.
Sasikumar M; Oommen AM; Mohan VR; Gupta P; Rebekah G; Abraham VJ; George K
Indian Heart J; 2023; 75(1):47-52. PubMed ID: 36638887
[TBL] [Abstract][Full Text] [Related]
5. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV.
van Zoest RA; Law M; Sabin CA; Vaartjes I; van der Valk M; Arends JE; Reiss P; Wit FW
J Acquir Immune Defic Syndr; 2019 Aug; 81(5):562-571. PubMed ID: 31045648
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic Women's Health Initiative.
Cook NR; Paynter NP; Eaton CB; Manson JE; Martin LW; Robinson JG; Rossouw JE; Wassertheil-Smoller S; Ridker PM
Circulation; 2012 Apr; 125(14):1748-56, S1-11. PubMed ID: 22399535
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. External validation of three atherosclerotic cardiovascular disease risk equations in rural areas of Xinjiang, China.
Jiang Y; Ma R; Guo H; Zhang X; Wang X; Wang K; Hu Y; Keerman M; Yan Y; Ma J; Song Y; Zhang J; He J; Guo S
BMC Public Health; 2020 Sep; 20(1):1471. PubMed ID: 32993590
[TBL] [Abstract][Full Text] [Related]
9. Validation of Risk Prediction Models for Atherosclerotic Cardiovascular Disease in a Prospective Korean Community-Based Cohort.
Bae JH; Moon MK; Oh S; Koo BK; Cho NH; Lee MK
Diabetes Metab J; 2020 Jun; 44(3):458-469. PubMed ID: 31950769
[TBL] [Abstract][Full Text] [Related]
10. Temporal trends in cardiovascular risk factors and performance of the Framingham Risk Score and the Pooled Cohort Equations.
Rospleszcz S; Thorand B; de Las Heras Gala T; Meisinger C; Holle R; Koenig W; Mansmann U; Peters A
J Epidemiol Community Health; 2019 Jan; 73(1):19-25. PubMed ID: 30262553
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk model performance in women with and without hypertensive disorders of pregnancy.
Dam V; Onland-Moret NC; Verschuren WMM; Boer JMA; Benschop L; Franx A; Moons KGM; Boersma E; van der Schouw YT;
Heart; 2019 Feb; 105(4):330-336. PubMed ID: 30209122
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular disease risk prediction in sub-Saharan African populations - Comparative analysis of risk algorithms in the RODAM study.
Boateng D; Agyemang C; Beune E; Meeks K; Smeeth L; Schulze MB; Addo J; de-Graft Aikins A; Galbete C; Bahendeka S; Danquah I; Agyei-Baffour P; Owusu-Dabo E; Mockenhaupt FP; Spranger J; Kengne AP; Grobbee DE; Klipstein-Grobusch K
Int J Cardiol; 2018 Mar; 254():310-315. PubMed ID: 29407113
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Framingham General Cardiovascular Risk Score and Pooled Cohort Equations in a Community-Based Population: A Prospective Cohort Study Analysis 2006-2017.
Jian JZ; Tzeng IS; Hsieh CF; Huang HL; Chen CL; Liu KL
Acta Cardiol Sin; 2023 Nov; 39(6):879-887. PubMed ID: 38022424
[TBL] [Abstract][Full Text] [Related]
14. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cardiovascular risk assessment algorithms to determine eligibility for statin therapy: implications for practice in Canada.
Mancini GB; Ryomoto A
Can J Cardiol; 2014 Jun; 30(6):661-6. PubMed ID: 24882538
[TBL] [Abstract][Full Text] [Related]
16. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
[TBL] [Abstract][Full Text] [Related]
17. Population-Based Recalibration of the Framingham Risk Score and Pooled Cohort Equations.
Sud M; Sivaswamy A; Chu A; Austin PC; Anderson TJ; Naimark DMJ; Farkouh ME; Lee DS; Roifman I; Thanassoulis G; Tu K; Udell JA; Wijeysundera HC; Ko DT
J Am Coll Cardiol; 2022 Oct; 80(14):1330-1342. PubMed ID: 36175052
[TBL] [Abstract][Full Text] [Related]
18. Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study.
Nishimura K; Okamura T; Watanabe M; Nakai M; Takegami M; Higashiyama A; Kokubo Y; Okayama A; Miyamoto Y
J Atheroscler Thromb; 2014; 21(8):784-98. PubMed ID: 24671110
[TBL] [Abstract][Full Text] [Related]
19. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis.
Wallisch C; Heinze G; Rinner C; Mundigler G; Winkelmayer WC; Dunkler D
Int J Cardiol; 2019 May; 283():165-170. PubMed ID: 30429082
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
